Prognostic factors in primary diffuse large B-cell lymphoma of adrenal gland treated with rituximab-CHOP chemotherapy from the Consortium for Improving Survival of Lymphoma (CISL)
<p>Abstract</p> <p>Background</p> <p>The objective of this study was to identify prognostic factors for survival in patients with primary diffuse large B-cell lymphoma (DLBCL) of the adrenal gland.</p> <p>Methods</p> <p>Thirty one patients diagnosed with primary adrenal DLBCL from 14 Korean institut...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BMC
2012-08-01
|
| Schriftenreihe: | Journal of Hematology & Oncology |
| Schlagworte: | |
| Online-Zugang: | http://www.jhoonline.org/content/5/1/49 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|
